Nimble Therapeutics, Inc. — Form D

Nimble Therapeutics, Inc. of Madison, WI, a company, filed a Form D exempt-offering notice with the SEC on 2019-04-11. The offering totals $10.0M, of which $10.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2019-04-11
• Form: D
• Accession: 0001772745-19-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $10.0M
• Amount sold: $10.0M
• Investors: 3
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-337001

Issuer

• Name: Nimble Therapeutics, Inc.
• CIK: 0001772745
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2019
• Address: 500 South Rosa Road Suite 601, Madison, WI, 53719
• Phone: 608-257-3501

Officers, directors & promoters (7)

More

• CIK 1772745 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search